These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2967259)

  • 21. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
    Liu W; Liu P; Tao S; Deng Y; Li X; Lan T; Zhang X; Guo F; Huang W; Chen F; Huang H; Zhou SF
    Arch Biochem Biophys; 2008 Jul; 475(2):128-34. PubMed ID: 18471986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldose reductase inhibitor ONO-2235 restores the alterations of bladder nerve growth factor and neurotrophin receptor p75 genetic expression in streptozotocin induced diabetic rats.
    Tong YC; Cheng JT
    J Urol; 2007 Nov; 178(5):2203-7. PubMed ID: 17870109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
    Ohguro N; Matsuda M; Ohashi Y; Fukuda M
    Br J Ophthalmol; 1995 Dec; 79(12):1074-7. PubMed ID: 8562538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
    Hosotani H; Ohashi Y; Kinoshita S; Matsumoto T; Awata T
    Curr Eye Res; 1996 Oct; 15(10):1005-7. PubMed ID: 8921238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.
    Nakahara M; Miyata K; Otani S; Miyai T; Nejima R; Yamagami S; Amano S
    Br J Ophthalmol; 2005 Mar; 89(3):266-8. PubMed ID: 15722300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Submicroscopic restructurings in the glomerular portion of the rat nephron in streptozotocin diabetes and their possible drug correction].
    Zurnadzhi IuN; Efimov AS; Bogdanova TI; Mel'nik IM; Bragarnik MN
    Probl Endokrinol (Mosk); 1987; 33(3):54-9. PubMed ID: 3116529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
    Ohashi Y; Matsuda M; Hosotani H; Tano Y; Ishimoto I; Fukuda M; Manabe R
    Am J Ophthalmol; 1988 Mar; 105(3):233-8. PubMed ID: 3125744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corneal abnormalities in diabetes.
    Siribunkum J; Kosrirukvongs P; Singalavanija A
    J Med Assoc Thai; 2001 Aug; 84(8):1075-83. PubMed ID: 11758839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of corneal endothelial structure between diabetes and non-diabetes.
    Leelawongtawun W; Suphachearaphan W; Kampitak K; Leelawongtawun R
    J Med Assoc Thai; 2015 May; 98(5):484-8. PubMed ID: 26058277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial changes in galactose-fed dogs.
    Neuenschwander H; Julia C; Wyman M; Kador PF
    Curr Eye Res; 1995 Apr; 14(4):319-22. PubMed ID: 7606918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
    Hosotani H; Ohashi Y; Yamada M; Tsubota K
    Am J Ophthalmol; 1995 Mar; 119(3):288-94. PubMed ID: 7872388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition.
    Zoubi SA; Williams MD; Mayhew TM; Sparrow RA
    Virchows Arch; 1995; 427(2):187-93. PubMed ID: 7582250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal endothelial cytoskeletal changes in F-actin with aging, diabetes, and after cytochalasin exposure.
    Kim EK; Geroski DH; Holley GP; Urken SI; Edelhauser HF
    Am J Ophthalmol; 1992 Sep; 114(3):329-35. PubMed ID: 1524124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical aldose reductase inhibitor.
    Coster D
    Br J Ophthalmol; 1995 Dec; 79(12):1064-5. PubMed ID: 8562535
    [No Abstract]   [Full Text] [Related]  

  • 36. [Corneal endothelial healing in galactosemic rats proliferation of residual endothelial cells].
    Ibaraki N; Terubayashi H; Akagi Y; Tutumi M; Yokoi N; Okamoto S; Itoi M
    Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):423-32. PubMed ID: 3137793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Proliferation of corneal epithelial cells in diabetic rats].
    Yamamoto N; Katakami C; Yamamoto M
    Nippon Ganka Gakkai Zasshi; 1998 Aug; 102(8):475-80. PubMed ID: 9754017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular development and aging. 1. Corneal endothelial changes in cats and in free-ranging and caged rhesus monkeys.
    Baroody RA; Bito LZ; DeRousseau CJ; Kaufman PL
    Exp Eye Res; 1987 Oct; 45(4):607-22. PubMed ID: 3428387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of aldose reductase inhibitor on the corneal epithelium.
    Tsubota K; Yamada M
    Cornea; 1993 Mar; 12(2):161-2. PubMed ID: 8500324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corneal endothelial changes in type I and type II diabetes mellitus.
    Schultz RO; Matsuda M; Yee RW; Edelhauser HF; Schultz KJ
    Am J Ophthalmol; 1984 Oct; 98(4):401-10. PubMed ID: 6486211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.